336 related articles for article (PubMed ID: 15466638)
1. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
2. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Panfilov VI
Chest; 2007 Jul; 132(1):120-6. PubMed ID: 17475630
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
Spiecker M; Liao J
Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.
Wang CP; Hung WC; Yu TH; Chiu CA; Lu LF; Chung FM; Hung CH; Shin SJ; Chen HJ; Lee YJ
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):346-52. PubMed ID: 20140850
[TBL] [Abstract][Full Text] [Related]
6. The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
Börgel J; Bulut D; Hanefeld C; Neubauer H; Mügge A; Epplen JT; Holland-Letz T; Spiecker M
BMC Cardiovasc Disord; 2008 Dec; 8():41. PubMed ID: 19105833
[TBL] [Abstract][Full Text] [Related]
7. A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China.
Zhu Q; Fu Z; Ma Y; Yang H; Huang D; Xie X; Liu F; Zheng Y; Cha E
Clin Biochem; 2013 Aug; 46(12):1047-1054. PubMed ID: 23684773
[TBL] [Abstract][Full Text] [Related]
8. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Ivakin VE; Katargina LN; Kolesnikova OE
Dis Markers; 2008; 24(2):119-26. PubMed ID: 18219097
[TBL] [Abstract][Full Text] [Related]
9. CYP2J2*7 single nucleotide polymorphism in a Chinese population.
Wang H; Jiang Y; Liu Y; Lin C; Cheng G; Chen X; Hao B; Tan W; Lin D; He F
Clin Chim Acta; 2006 Mar; 365(1-2):125-8. PubMed ID: 16182271
[TBL] [Abstract][Full Text] [Related]
10. Cloning of CYP2J2 gene and identification of functional polymorphisms.
King LM; Ma J; Srettabunjong S; Graves J; Bradbury JA; Li L; Spiecker M; Liao JK; Mohrenweiser H; Zeldin DC
Mol Pharmacol; 2002 Apr; 61(4):840-52. PubMed ID: 11901223
[TBL] [Abstract][Full Text] [Related]
11. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC
Pharmacogenet Genomics; 2007 May; 17(5):349-58. PubMed ID: 17429317
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Moshal KS; Zeldin DC; Sithu SD; Sen U; Tyagi N; Kumar M; Hughes WM; Metreveli N; Rosenberger DS; Singh M; Vacek TP; Rodriguez WE; Ayotunde A; Tyagi SC
J Cell Physiol; 2008 Jun; 215(3):771-81. PubMed ID: 18181170
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome epoxygenase (CYP2J2) in the pathophysiology of coronary artery disease in South Indian population.
Tantray JA; Reddy KP; Jamil K; Yerra SK
Indian Heart J; 2019; 71(1):60-64. PubMed ID: 31000184
[TBL] [Abstract][Full Text] [Related]
16. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
20. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Goldsworthy SM; Cook ME; Boyle JE; Ma J; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1997 Jun; 51(6):931-43. PubMed ID: 9187259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
